Articles dans des revues avec comité de lecture (156)
118.
Haibe-Kains, B., Desmedt, C., Loi, S., Delorenzi, M., Sotiriou, C., & Bontempi, G. (2008). Computational intelligence in clinical oncology: Lessons learned from an analysis of a clinical study. Studies in Computational Intelligence, 151, 237-268. doi:10.1007/978-3-540-70778-3_10119.
Kontos, K., Godard, P., André, B., van Helden, J., & Bontempi, G. (2008). Machine learning techniques to identify putative genes involved in nitrogen catabolite repression in the yeast Saccharomyces cerevisiae. B M C Proceedings, 2 Suppl 4, S5.122.
Loi, S., Haibe-Kains, B., Desmedt, C., Wirapati, P., Lallemand, F., Tutt, A. M., Gillet, C., Ellis, P., Ryder, K., Reid, J. F., Daidone, M. G., Pierotti, M. A., Berns, E. M., Jansen, M. P., Foekens, J. A., Delorenzi, M., Bontempi, G., Piccart-Gebhart, M., & Sotiriou, C. (2008). Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen. BMC genomics, 9, 239. doi:10.1186/1471-2164-9-239123.
Haibe-Kains, B., Desmedt, C., Piette, F., Buyse, M., Cardoso, F., Van't Veer, L., Piccart-Gebhart, M., Bontempi, G., & Sotiriou, C. (2008). Comparison of prognostic gene expression signatures for breast cancer. BMC genomics, 9, 394. doi:10.1186/1471-2164-9-394125.
Megalizzi, V., Mathieu, V., Mijatovic, T., Gailly, P., Debeir, O., De Nève, N., Van Damme, M., Bontempi, G., Haibe-Kains, B., Decaestecker, C., Kondo, Y., Kiss, R., & Lefranc, F. (2007). 4-IBP, a sigma1 receptor agonist, decreases the migration of human cancer cells, including glioblastoma cells, in vitro and sensitizes them in vitro and in vivo to cytotoxic insults of proapoptotic and proautophagic drugs. Neoplasia (New York, N.Y.), 9(5), 358-369.127.
Godard, P., Urrestarazu, A., Vissers, S., Kontos, K., Bontempi, G., van Helden, J., & André, B. (2007). Effect of 21 different nitrogen sources on global gene expression in the yeast Saccharomyces cerevisiae. Molecular and cellular biology, 27(8), 3065-3086. doi:10.1128/MCB.01084-06128.
Loi, S., Haibe-Kains, B., Desmedt, C., Lallemand, F., Tutt, A. M., Gillet, C., Ellis, P., Harris, A., Bergh, J., Foekens, J. A., Klijn, J. G., Larsimont, D., Buyse, M., Bontempi, G., Delorenzi, M., Piccart-Gebhart, M., & Sotiriou, C. (2007). Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade. Journal of clinical oncology, 25(10), 1239-1246. doi:10.1200/JCO.2006.07.1522